Starling Oncology STLN
$3.62 −$3.08 (-45.97%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $3.63 +0.28%
Open$6.06
Prev close$6.70
Day range$3.35 – $6.43
Volume23.92M
Market cap$369.21M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$161.28M+34.6% YoY
Operating profit-$4.62M+58.8% YoY
Net profit-$9.79M+42.4% YoY
Diluted EPS-$0.08+46.7% YoY
Free cash flow$11.03M+196.7% YoY
Operating cash flow$11.94M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin15.7%
Operating margin-4.4%
Net margin-5.2%
Return on assets-18.1%
Current ratio1.36
Liabilities / assets114.0%
Cash & investments$41.09M
Total debt$97.25M
Net cash (debt)-$56.16M
Where the revenue comes from
Quarter 2026/Q2
By business line
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $161.28M | $147.44M | $502.73M | $141.96M | $136.56M |
| Total Operating Revenue | $161.28M | $147.44M | $502.73M | $141.96M | $136.56M |
| Cost of Revenue | $134.12M | $124.13M | $426.29M | $119.19M | $117.64M |
| Gross Profit | $27.17M | $23.32M | $76.44M | $22.77M | $18.92M |
| Operating Expense | $31.78M | $29.83M | $112.52M | $29.67M | $26.97M |
| Selling and Admin Expenses | $29.94M | $28.21M | $105.57M | $28.04M | $25.25M |
| Depreciation & Amortization & Depletion | $1.84M | $1.62M | $6.94M | $1.63M | $1.72M |
| -Depreciation & Amortization | $1.84M | $1.62M | $6.94M | $1.63M | $1.72M |
| Operating Profit | -$4.62M | -$6.51M | -$36.08M | -$6.91M | -$8.05M |
| Net Non-Operating Interest Income (Expense) | -$1.86M | -$1.93M | -$11.28M | -$1.92M | -$1.92M |
| Non-Operating Interest Expense | $1.86M | $1.93M | $11.28M | $1.92M | $1.92M |
| Other Income (Expense) | -$3.31M | $5.96M | -$13.38M | $1.32M | -$6.53M |
| Gain on Sale of Security | -$3.24M | $5.16M | -$12.45M | $1.07M | -$6.13M |
| Other Non-Operating Income (Expenses) | -$77,000.00 | $791,000.00 | -$925,000.00 | $249,000.00 | -$403,000.00 |
| Pretax Profit | -$9.79M | -$2.49M | -$60.74M | -$7.51M | -$16.50M |
| Tax | $0.00 | $0.00 | -$131,000.00 | $0.00 | $0.00 |
| Net Profit | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| Profit from Continuing Operations | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| Net Income to Parent Company | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| Other Preferred Stock Dividends | -$1.55M | -$398,000.00 | -$10.30M | -$1.08M | -$2.73M |
| Net Income to Common Stockholders | -$8.24M | -$2.09M | -$50.31M | -$6.43M | -$13.77M |
| Basic EPS | -$0.08 | -$0.02 | -$0.54 | -$0.06 | -$0.14 |
| Diluted EPS | -$0.08 | -$0.02 | -$0.54 | -$0.06 | -$0.14 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $178.23M | $168.23M | $164.66M | $164.66M | $163.62M |
| Total Current Assets | $128.99M | $116.86M | $112.75M | $112.75M | $110.09M |
| Cash and Cash Equivalents & Short-Term Investments | $41.09M | $30.28M | $33.57M | $33.57M | $27.66M |
| -Cash and Cash Equivalents | $41.09M | $30.28M | $33.57M | $33.57M | $27.66M |
| Receivables | $66.71M | $59.45M | $59.32M | $59.32M | $59.98M |
| -Accounts Receivable | $66.35M | $58.13M | $59.00M | $59.00M | $59.64M |
| -Other Receivables | $360,000.00 | $1.32M | $322,000.00 | $322,000.00 | $300,000.00 |
| Inventory | $20.01M | $24.29M | $16.88M | $16.88M | $18.88M |
| Other Current Assets | $1.18M | $2.84M | $2.99M | $2.99M | $3.57M |
| Total Non-Current Assets | $49.24M | $51.37M | $51.91M | $51.91M | $53.53M |
| Net PPE | $31.77M | $33.22M | $33.06M | $33.06M | $33.98M |
| -Gross PPE | $44.64M | $45.04M | $43.98M | $43.98M | $43.99M |
| -Accumulated Depreciation | -$12.86M | -$11.83M | -$10.93M | -$10.93M | -$10.01M |
| Goodwill and Other Intangible Assets | $16.82M | $17.53M | $18.25M | $18.25M | $18.96M |
| -Goodwill | $7.23M | $7.23M | $7.23M | $7.23M | $7.23M |
| -Other Intangible Assets | $9.59M | $10.30M | $11.02M | $11.02M | $11.73M |
| Other Non-Current Assets | $657,000.00 | $620,000.00 | $606,000.00 | $606,000.00 | $586,000.00 |
| Total Liabilities | $203.15M | $184.52M | $180.38M | $180.38M | $175.89M |
| Total Current Liabilities | $94.94M | $79.35M | $70.96M | $70.96M | $65.58M |
| Payables | $60.28M | $47.65M | $43.17M | $43.17M | $35.63M |
| -Accounts Payable | $60.28M | $47.65M | $43.17M | $43.17M | $35.63M |
| Current Accrued Expenses | $13.08M | $9.78M | $5.20M | $5.20M | $2.74M |
| Short-Term Debt and Capital Lease Obligation | $7.23M | $7.40M | $7.16M | $7.16M | $7.16M |
| -Current Capital Lease Obligation | $7.23M | $7.40M | $7.16M | $7.16M | $7.16M |
| Current Deferred Liabilities | $2.50M | $3.05M | $4.04M | $4.04M | $7.34M |
| Other Current Liabilities | $6.24M | $5.67M | $4.31M | $4.31M | $4.71M |
| Total Non-Current Liabilities | $108.21M | $105.16M | $109.41M | $109.41M | $110.31M |
| Long Term Debt and Capital Lease Obligation | $97.25M | $97.45M | $96.53M | $96.53M | $96.39M |
| -Long Term Debt | $79.87M | $78.61M | $77.40M | $77.40M | $76.20M |
| -Long Term Capital Lease Obligation | $17.38M | $18.84M | $19.13M | $19.13M | $20.20M |
| Derivative Product Liabilities | $10.93M | $7.69M | $12.86M | $12.86M | $13.92M |
| Other Non-Current Liabilities | $30,000.00 | $19,000.00 | $28,000.00 | $28,000.00 | $3,000.00 |
| Total Equity | -$24.91M | -$16.29M | -$15.72M | -$15.72M | -$12.27M |
| Stockholders' Equity | -$24.91M | -$16.29M | -$15.72M | -$15.72M | -$12.27M |
| Capital Stock | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 |
| -Common Stock | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $259.80M | $258.64M | $256.71M | $256.71M | $252.65M |
| Retained Earnings | -$283.70M | -$273.91M | -$271.42M | -$271.42M | -$263.91M |
| Less: Treasury Stock | $1.02M | $1.02M | $1.02M | $1.02M | $1.02M |
| Non-Current Deferred Liabilities | – | – | $0.00 | $0.00 | $0.00 |
| -Accrued Interest Receivable | – | – | – | – | $39,000.00 |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $11.94M | -$2.22M | -$24.59M | $3.23M | -$12.63M |
| Net cash flow from continuing operations | $11.94M | -$2.22M | -$24.59M | $3.23M | -$12.63M |
| Net Income from Continuing Operations | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| Gain/Loss from Continuing Operations | $3.44M | -$5.16M | $14.85M | -$1.07M | $6.22M |
| Depreciation & Depletion & Amortization | $1.84M | $1.62M | $6.94M | $1.63M | $1.72M |
| Other Non-Cash Items | $1.08M | $1.21M | $8.38M | $1.21M | $1.08M |
| Change in Working Capital | $14.30M | $928,000.00 | $1.33M | $7.65M | -$6.17M |
| -Change in Receivables | -$7.26M | -$130,000.00 | -$12.58M | $658,000.00 | -$4.04M |
| -Change in Inventory | $4.28M | -$7.42M | -$6.84M | $2.01M | -$3.10M |
| -Change in Prepaid Assets | $1.67M | $144,000.00 | $2.03M | $230,000.00 | $553,000.00 |
| -Change in Payables and Accrued Expense | $15.94M | $8.53M | $19.19M | $4.87M | $566,000.00 |
| -Change in Other Current Assets | -$37,000.00 | -$14,000.00 | -$17,000.00 | -$20,000.00 | $0.00 |
| -Change in Other Current Liabilities | -$472,000.00 | $0.00 | -$11,000.00 | $84,000.00 | $122,000.00 |
| Net cash flow from investing | -$908,000.00 | -$1.04M | -$3.07M | -$1.06M | -$604,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$908,000.00 | -$1.04M | -$3.07M | -$1.06M | -$604,000.00 |
| Net PPE Purchase and Sale | -$908,000.00 | -$1.04M | -$3.20M | -$1.06M | -$604,000.00 |
| Financing Cash Flow | -$218,000.00 | -$28,000.00 | $11.56M | $3.73M | $10.60M |
| Net Cash Flow from Continuing Financing Activities | -$218,000.00 | -$28,000.00 | $11.56M | $3.73M | $10.60M |
| Net Issuance Payments Of Debt | -$8,000.00 | -$9,000.00 | -$20.04M | -$9,000.00 | -$8,000.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $29.20M | $3.89M | $9.95M |
| Proceeds from Stock Option Exercised | $90,000.00 | $241,000.00 | $3.44M | $204,000.00 | $891,000.00 |
| Net Other Financing Charges | -$300,000.00 | -$260,000.00 | -$1.04M | -$350,000.00 | -$235,000.00 |
| Ending Cash Balance | $41.09M | $30.28M | $33.57M | $33.57M | $27.66M |
| Net Change in Cash | $10.81M | -$3.29M | -$16.10M | $5.91M | -$2.63M |
| Beginning Cash Balance | $30.28M | $33.57M | $49.67M | $27.66M | $30.29M |
| Free Cash Flow | $11.03M | -$3.26M | -$27.79M | $2.17M | -$13.23M |
| -Change In Other Working Capital | – | -$186,000.00 | -$452,000.00 | -$178,000.00 | – |
| Deferred Tax | – | – | -$32,000.00 | $0.00 | $0.00 |
| Net Investment Purchase and Sale | – | – | $0.00 | $0.00 | – |
| Net Other Investing Changes | – | – | $126,000.00 | $0.00 | $0.00 |
No comments yet — be the first to weigh in on STLN.
Sign in to join the discussion.